Bivalent Oral Polio Vaccine in healthy infants- A Phase IV study
Phase 4
- Registration Number
- CTRI/2017/02/007813
- Lead Sponsor
- S K Tyagi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Newborn infants with an APGAR score > 7 when measured 1 minute after birth
Infants who have not been previously vaccinated against poliomyelitis
Infants born at full term pregnancy with a birth weight >= 2.5 Kg
Exclusion Criteria
Infants born before the 37th week of gestation or weighing less then 2.5 kg at birth.
History of immunization with â??zero doseâ?? of OPV.
Newborn infants who are participating in any other investigatory study.
Newborn infants currently receiving immuno suppressant drugs.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method